ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,826.91
      -1.54%
      US Tech 100
      20,288.80
      -1.56%
      Dow Jones
      41,936.11
      -1.64%
      Brent Oil
      79.365
      3.17%
      Bitcoin
      94,771.52
      2.55%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Adaptive Biotechnologies Corporation (ADPT) Quote

      Adaptive Biotechnologies Corporation

      Adaptive Biotechnologies Corporation (ADPT)

      Adaptogenics Health Corp
      6.425
      -0.265
      ( -3.96% )
      Updated: 15:41:14
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      6.425
      Bid
      6.42
      Ask
      6.43
      Volume
      810,175
      6.23 Day's Range 6.57
      2.28 52 Week Range 7.46
      Market Cap
      948.198M
      Previous Close
      6.69
      Open
      6.48
      Last Trade
      11
      @
      6.4207
      Last Trade Time
      15:41:19
      Financial Volume
      $ 5,198,602
      VWAP
      6.4166
      Average Volume (3m)
      1,233,530
      Shares Outstanding
      147,579,486
      Dividend Yield
      -
      PE Ratio
      -4.21
      Earnings Per Share (EPS)
      -1.53
      Revenue
      170.28M
      Net Profit
      -225.25M

      About Adaptive Biotechnologies Corporation

      Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.adaptivebiotech.com
      Headquarters
      Olympia, Washington, USA
      Founded
      -
      Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADPT. The last closing price for Adaptive Biotechnologies was $6.69. Over the last year, Adaptive Biotechnologies shares have traded in a share price range of $ 2.28 to $ 7.46.

      Adaptive Biotechnologies currently has 147,579,486 shares outstanding. The market capitalization of Adaptive Biotechnologies is $987.31 million. Adaptive Biotechnologies has a price to earnings ratio (PE ratio) of -4.21.

      Ask ADVFN Intelligence (AI)

      ADPT Latest News

      More News

      Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for clonoSEQ® Test for Minimal Residual Disease Assessment is Effective as of January 1st, 2025

      SEATTLE, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

      January 07 2025
      GlobeNewswire Inc.

      Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

      SEATTLE, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

      January 02 2025
      GlobeNewswire Inc.

      Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions

      New data demonstrate the actionability of clonoSEQ for tailoring treatment decisions in patients with MCL, CLL, MM and ALL Studies show depth of response at 10-6 provides more accurate assessment...

      December 07 2024
      GlobeNewswire Inc.

      Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting

      SEATTLE, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

      December 03 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      November 19 2024
      Edgar (US Regulatory)

      Form SC 13G - Statement of Beneficial Ownership by Certain Investors

      November 13 2024
      Edgar (US Regulatory)

      Form SC 13G - Statement of Beneficial Ownership by Certain Investors

      November 08 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 07 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 07 2024
      Edgar (US Regulatory)

      Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results

      SEATTLE, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...

      November 07 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.0450.7053291536056.387.466.2320403427.00478505CS
      40.3054.983660130726.127.465.80512338196.57299876CS
      121.76537.87553648074.667.464.2712335305.79176793CS
      262.89582.01133144483.537.463.4712080655.11759615CS
      521.79538.76889848814.637.462.2813946934.16000134CS
      156-16.005-71.355327686122.4323.062.2813020936.83821667CS
      260-23.525-78.547579298829.9571.252.28114597417.28047869CS

      ADPT - Frequently Asked Questions (FAQ)

      What is the current Adaptive Biotechnologies share price?
      The current share price of Adaptive Biotechnologies is $ 6.425
      How many Adaptive Biotechnologies shares are in issue?
      Adaptive Biotechnologies has 147,579,486 shares in issue
      What is the market cap of Adaptive Biotechnologies?
      The market capitalisation of Adaptive Biotechnologies is USD 987.31M
      What is the 1 year trading range for Adaptive Biotechnologies share price?
      Adaptive Biotechnologies has traded in the range of $ 2.28 to $ 7.46 during the past year
      What is the PE ratio of Adaptive Biotechnologies?
      The price to earnings ratio of Adaptive Biotechnologies is -4.21
      What is the cash to sales ratio of Adaptive Biotechnologies?
      The cash to sales ratio of Adaptive Biotechnologies is 5.57
      What is the reporting currency for Adaptive Biotechnologies?
      Adaptive Biotechnologies reports financial results in USD
      What is the latest annual turnover for Adaptive Biotechnologies?
      The latest annual turnover of Adaptive Biotechnologies is USD 170.28M
      What is the latest annual profit for Adaptive Biotechnologies?
      The latest annual profit of Adaptive Biotechnologies is USD -225.25M
      What is the registered address of Adaptive Biotechnologies?
      The registered address for Adaptive Biotechnologies is 711 CAPITOL WAY S STE 204, UNITED STATES, OLYMPIA, WASHINGTON, 98501 1267
      What is the Adaptive Biotechnologies website address?
      The website address for Adaptive Biotechnologies is www.adaptivebiotech.com
      Which industry sector does Adaptive Biotechnologies operate in?
      Adaptive Biotechnologies operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      VRMEVerifyMe Inc
      $ 2.76
      (64.29%)
      		55.35M
      DATSDatChat Inc
      $ 5.24
      (63.24%)
      		154.02M
      VMARVision Marine Technologies Inc
      $ 2.45
      (61.18%)
      		170.03M
      WKEYWISeKey International Holdings AG
      $ 10.185
      (55.02%)
      		5.81M
      CDTConduit Pharmaceuticals Inc
      $ 0.1266
      (54.39%)
      		1.14B
      IGMSIGM Biosciences Inc
      $ 2.17
      (-65.00%)
      		5.18M
      AIFUAIX Inc
      $ 0.3933
      (-51.14%)
      		7.24M
      CDTGCDT Environmental Technology Investment Holdings Ltd
      $ 1.9034
      (-50.43%)
      		2.2M
      MODVModivCare Inc
      $ 6.685
      (-46.48%)
      		2.02M
      XTIAXTI Aerospace Inc
      $ 7.33
      (-41.94%)
      		5.95M
      CDTConduit Pharmaceuticals Inc
      $ 0.1266
      (54.39%)
      		1.14B
      VMARVision Marine Technologies Inc
      $ 2.45
      (61.18%)
      		170.03M
      NVDANVIDIA Corporation
      $ 135.72
      (-3.13%)
      		168.32M
      RGTIRigetti Computing Inc
      $ 9.09
      (-9.46%)
      		155.44M
      DATSDatChat Inc
      $ 5.24
      (63.24%)
      		154.02M

      Discussion

      View Full Feed
      quester614 quester614 5 minutes ago
      There will be thousands that can't rebuild because State Farm and others DROPPED them. NOT BECAUSE OF NOT USING NANO TECH. What happened to using the TF 600 over in Ukraine like you pumped. LOLOLOLOL
      XERI
      Catpole Catpole 5 minutes ago
      Get ready, get set, ??????.
      APRU
      DiscoverGold DiscoverGold 5 minutes ago
      $META Major Call Selling Millions worth of OTM September calls were just sold to open
      By: Cheddar Flow | January 10, 2025

      • $META Major Call Selling

      Millions worth of OTM September calls were just sold to open

      Even the calls that were execu
      META
      sortagreen sortagreen 5 minutes ago
      It speaks to the essential corruption of so much of the electorate.

      You're a weak, pathetic excuse for a man. You genuinely suck.
      Fully Diluted Fully Diluted 6 minutes ago
      It could happen at any time that Trump nominates a head for the FHFA. We are all waiting to finally find out who will lead the FHFA.

      Bob Corker wanted to wind down Fannie and Freddie. He even recommended shorting the stocks in an interview. I'm sure you can imagine how wildly popular
      FNMA
      rbl100 rbl100 6 minutes ago
      Falling knife and so glad I avoided the hype. Done with gambling. Sorry for those who are bagholders. Been there done that.
      RGTI
      Pic Pic 6 minutes ago
      That is exciting news.
      FDCT
      work-n-hard work-n-hard 6 minutes ago
      PLUG: Probably the reason for the rise>>>>>
      Check all of Hunterbrook's posts.

      https://x.com/hntrbrkmedia/status/1877813902727364850
      TMaga TMaga 6 minutes ago
      Don't worry, Clyde is making money. That's all that matters, isn't it ???
      Clyde already paid himself $1 million to run a failed company and another $`12 million in preferred shares he gave himself just before transferring all the assets from HCMC to this other SCAM.
      More wardrobes for
      HCMC
      pitcook pitcook 7 minutes ago
      Which statement is more accurate?

      We have nothing until we have everything, and the only thing that matters is in the labs testing our material, to see if it works with their materials?


      It Is DEALLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLTIME!!!!!!!!!!!!!!
      LWLG
      janice shell janice shell 7 minutes ago
      I suspect I have more experience with elite schools than you do. Sure, it's an entree to good jobs. But it's no guarantee. Ivanka's success is thanks to her father. And then there're Jared and his billions from the Saudis. Also thanks to Donnie.
      rbl100 rbl100 7 minutes ago
      Falling knife and so glad I avoided the hype. Done with gambling. Sorry for those who are bagholders. Been there done that.
      QUBT
      DiscoverGold DiscoverGold 7 minutes ago
      $SPY Large $2+ Million OTM Put Seller (Highly Unusual)
      By: Cheddar Flow | January 10, 2025

      • $SPY Large $2M+ OTM Put Seller (Highly Unusual)

      This whale wants to collect the heightened premium on these contracts

      *Below the Bid*

      SPY
      Slojab Slojab 7 minutes ago
      No, I don't believe they were unaware that it was dual listed. They've just pretty much acted like it wasn't. Obviously, the fix isn't a simple one and it doesn't seem like they're doing anything much to fix it, which is baffling.

      And like you, I find it more than a little annoying t
      TWOH
      Genz2 Genz2 7 minutes ago
      https://www.securitywizardry.com/boundary-guard-products/guards-authentication/wave-virtual-smart-card
      Viking61 Viking61 7 minutes ago
      How about Persistent Patients Pays Off i😂
      FNMA
      trusttheman trusttheman 7 minutes ago
      St3 will be in prison soon. You can tell he’s worried about it because the last time I posted this it was deleted. Say goodbye to house St3 and your woman. Both will be occupied by someone else soon.
      TPTW
      againstallodds againstallodds 7 minutes ago
      Pump has faded

      A stupid pic sure ain’t no catalyst
      NBRI
      PonkenPlonken PonkenPlonken 7 minutes ago
      what is up with that?:
      Post #479,664
      AVXL
      Viking61 Viking61 7 minutes ago
      How about Persistent Patients Pays Off i😂
      FNMA
      PennyMillions852 PennyMillions852 7 minutes ago
      Oh cry me a river TROLL of all boards! 😂😂
      SINC
      QuantumCorsair12 QuantumCorsair12 8 minutes ago
      Lol and the crow moderates the board, uses multiple accounts to bash to try to get cheap shares and then deletes comments calling him out. What a pathetic loser
      RDAR
      canthelpit canthelpit 8 minutes ago
      I belive in one of the filings by march for the BANNIX deal ,,, They have pushed their luck with the time line to form a company and should have already disolved from the guid lines I read,,,, Might be some big changes with leadership change on the 20th of this month when ginsler steps aside ,,, j
      GTCH
      LarryBear40 LarryBear40 8 minutes ago
      19's
      AAGC
      georgejjl georgejjl 8 minutes ago
      Notice stock option trading and expiration dates next Thursday 16 January 2025. In synchronicity with the JPM presentation

      https://www.optionseducation.org/getattachment/3316b3e6-3da8-45e0-b858-5dc0bc9a2c5b/2025-Expiration-Calendar-12-21.pdf?lang=en-US&ext=.pdf

      Good luc
      JPM

      Your Recent History

      NASDAQ
      ADPT
      Adaptive Biotechnologies
      BIT
      S31312
      Societe Generale Effekten
      BOV
      RCSL4
      RECRUSUL PN
      BIT
      F08958
      Vontobel Financial Produ...
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads